SETTLEMENT AGREEMENT AND GENERAL AND MUTUAL RELEASESettlement Agreement • April 3rd, 2024 • Titan Pharmaceuticals Inc • Biological products, (no disgnostic substances) • California
This Settlement Agreement and General and Mutual Release (the “Agreement”) is on this 2nd day of April by and between Titan Pharmaceuticals, Inc. (the “Company”) and Katherine Beebe DeVarney, Ph.D. (the “Executive”), collectively known herein as the “Parties.”
AGREEMENTDirector Services Agreement • April 3rd, 2024 • Titan Pharmaceuticals Inc • Biological products, (no disgnostic substances) • California
This Agreement (the “Agreement”) is made on this 2nd day of April by and between Titan Pharmaceuticals, Inc. (the “Company”) and Avraham Ben-Tzvi (the “Director”), collectively known herein as the “Parties.”
FORM OF SETTLEMENT AGREEMENT AND GENERAL AND MUTUAL RELEASESettlement Agreement • April 3rd, 2024 • Titan Pharmaceuticals Inc • Biological products, (no disgnostic substances) • California
This Settlement Agreement and General and Mutual Release (the “Agreement”) is on this 2nd day of April by and between Titan Pharmaceuticals, Inc. (the “Company”) and [____] (the “Director”), collectively known herein as the “Parties.”
SETTLEMENT AGREEMENT AND GENERAL AND MUTUAL RELEASESettlement Agreement • April 3rd, 2024 • Titan Pharmaceuticals Inc • Biological products, (no disgnostic substances) • California
This Settlement Agreement and General and Mutual Release (the “Agreement”) is on this 2nd day of April by and between Titan Pharmaceuticals, Inc. (the “Company”) and David Lazar (the “Executive”), collectively known herein as the “Parties.”
